Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Janssen’s single-tablet antiretroviral regimen was approved on July 17.
HIV-positive women who breastfeed can protect their infants from infection for a year after birth by giving them a liquid form of PrEP.
Every decade spent living with HIV is equivalent to an additional 10 years of ordinary aging’s contribution to heart attack risk.
Medications used to boost the levels of other HIV antiretrovirals are the most likely out of all ARVs to have dangerous interactions with...
People with HIV who take Viread, Norvir, Reyataz or Norvir-boosted Kaletra are at increasing risk of kidney disease over time.
The agreement will allow for the generic production of HIV meds lopinavir and ritonavir.
Taking a triple-antiretroviral regimen is best for preventing mother-to-child transmission during pregnancy, rather than taking one drug durin...
The FDA has approved Gilead Sciences’ integrase strand transfer inhibitor Vitekta (elvitegravir) for treatment-experienced HIV-positive...
Ugandans with HIV who begin treatment with higher CD4 counts can do quite well on therapy
Treating HIV with a dual regimen of Kaletra and Epivir is as effective as a standard triple regimen of Kaletra plus two NRTIs.
Cutting the standard dose of Kaletra by 30 percent does not change its efficacy at suppressing HIV and it improves abnormal lipid levels among...
The U.S. Food and Drug Administration has made changes to the label for the single-pill HIV antiretroviral combination therapy Atripla.
Pregnant women’s use of protease inhibitors, but not nukes or non-nukes, in the first trimester increases their risk of premature birth.
Victrelis (boceprevir), Merck’s hepatitis C virus (HCV) protease inhibitor, should not be combined with the following Norvir (ritonavir)...
The hepatitis C protease inhibitor Victrelis (boceprevir) has some significant drug-drug interactions with common Norvir (ritonavir)?boosted p...
Crushing Kaletra (lopinavir/ritonavir) tablets to make the medication easier to take by children should be avoided, according to a new paper p...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.